Avinger-about-hero-mobile Avinger-about-hero-tablet
about_avinger

We’re radically changing the way
vascular disease is treated

Our Story

Vascular disease isn’t going away. Real people continue to fight the progression and complications that result from PAD. We’ve won many battles but the war goes on and we don’t take our responsibility to create change lightly. As our company ages, many of our ideas have become realities yet we still lie awake at night devising plans to do more. We know many are counting on us to do more. We continue to be an ordinary group of individuals trying to achieve the extraordinary. For this opportunity we remain extremely blessed.

Leadership

  • Jeff2
    Jeffrey M. Soinski Chief Executive Officer
  • Himanshu2
    Himanshu Patel Chief Technology Officer
  • Phil-Preuss-Straight BW
    Phil Preuss Chief Commercial Officer
  • Lawson 222
    Lawson, PhD Vice President, Clinical & Regulatory Affairs
  • Dr. Davis
    Thomas P. Davis, MD, FACC Chief Medical Officer
  • jay-sundaram4
    Jay Sundaram Vice President, Quality
    Management Representative
  • elmar horn
    Elmar Horn Vice President, International
  • Nabeel Subainati
    Nabeel Subainati Vice President, Finance
SEE MORE
  • 222
    James G. Cullen Chairman
  • Jeff2
    Jeffrey M. Soinski Chief Executive Officer & Director
  • 221
    James B. McElwee Director
  • Tamara-Elias
    Tamara Elias, M.D. Director
SEE MORE
banner-img03

Careers

Join us as we develop powerful new weapons in the fight against Peripheral Artery Disease.

SEE OUR OPEN POSITIONS

Avinger in the News

For media outreach and inquiries, please contact press@avinger.com to tell us your story.